Search research articles
Contact Us
Filters
Showing results (21-30 of 51) with videos related to
Page
of 6
Sort By:
Life Sciences
|
January 1, 1995
In vitro characterization of the non-peptide tachykinin NK1 and NK2-receptor antagonists, SR140333 and SR48968 in different rat and guinea-pig intestinal segments
T Croci, X Emonds-Alt, G Le Fur, et al.
Life Sciences
|
November 15, 1982
Morphine inhibits gastrointestinal transit in the rat primarily by impairing propulsive activity of the small intestine
R Fiocchi, G Bianchi, P Petrillo, et al.
British Journal of Industrial Medicine
|
November 1, 1976
Excretion of 35S-Tobias acid (2-naphthylamino, 1-sulphonic acid) by the rat after oral and intravenous administration
M A Marchisio, M Dubini, G Serra, et al.
British Journal of Pharmacology
|
June 1, 1995
Promotion by SR 48692 of gastric emptying and defaecation in rats suggesting a role of endogenous neurotensin
T Croci, A Giudice, L Manara, et al.
Life Sciences
|
September 20, 1982
Inhibition of gastrointestinal transit by morphine and FK 33-824 in the rat and comparative narcotic antagonist properties of naloxone and its N-methyl quaternary analog
L Manara, G Bianchi, R Fiocchi, et al.
The Journal of Pharmacy and Pharmacology
|
May 1, 1984
The peripheral narcotic antagonist N-allyl levallorphan-bromide (CM 32191) selectively prevents morphine antipropulsive action and buprenorphine in-vivo binding in the rat intestine
G Bianchi, R Fiocchi, F Peracchia, et al.
Pharmacological Research Communications
|
August 1, 1988
Comparison of the gastric antisecretory effects of ramixotidine dihydrochloride (CM 57755), a new H2 receptor antagonist, and cimetidine in dogs
G Soldani, A Lavezzo, A Bianchetti, et al.
The Journal of Pharmacy and Pharmacology
|
October 1, 1984
Central and peripheral inhibition of gastrointestinal transit in rats: narcotics differ substantially by acting at either or both levels
F Peracchia, G Bianchi, R Fiocchi, et al.
Gastroenterology
|
October 1, 1983
Morphine tissue levels and reduction of gastrointestinal transit in rats. Correlation supports primary action site in the gut
G Bianchi, P Ferretti, M Recchia, et al.
British Journal of Pharmacology
|
April 1, 1996
Functional evidence of atypical beta 3-adrenoceptors in the human colon using the beta 3-selective adrenoceptor antagonist, SR 59230A
F De Ponti, G Gibelli, T Croci, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 51) with videos related to
Sort By:
Page
of 6
Life Sciences
|
January 1, 1995
In vitro characterization of the non-peptide tachykinin NK1 and NK2-receptor antagonists, SR140333 and SR48968 in different rat and guinea-pig intestinal segments
T Croci, X Emonds-Alt, G Le Fur, et al.
Life Sciences
|
November 15, 1982
Morphine inhibits gastrointestinal transit in the rat primarily by impairing propulsive activity of the small intestine
R Fiocchi, G Bianchi, P Petrillo, et al.
British Journal of Industrial Medicine
|
November 1, 1976
Excretion of 35S-Tobias acid (2-naphthylamino, 1-sulphonic acid) by the rat after oral and intravenous administration
M A Marchisio, M Dubini, G Serra, et al.
British Journal of Pharmacology
|
June 1, 1995
Promotion by SR 48692 of gastric emptying and defaecation in rats suggesting a role of endogenous neurotensin
T Croci, A Giudice, L Manara, et al.
Life Sciences
|
September 20, 1982
Inhibition of gastrointestinal transit by morphine and FK 33-824 in the rat and comparative narcotic antagonist properties of naloxone and its N-methyl quaternary analog
L Manara, G Bianchi, R Fiocchi, et al.
The Journal of Pharmacy and Pharmacology
|
May 1, 1984
The peripheral narcotic antagonist N-allyl levallorphan-bromide (CM 32191) selectively prevents morphine antipropulsive action and buprenorphine in-vivo binding in the rat intestine
G Bianchi, R Fiocchi, F Peracchia, et al.
Pharmacological Research Communications
|
August 1, 1988
Comparison of the gastric antisecretory effects of ramixotidine dihydrochloride (CM 57755), a new H2 receptor antagonist, and cimetidine in dogs
G Soldani, A Lavezzo, A Bianchetti, et al.
The Journal of Pharmacy and Pharmacology
|
October 1, 1984
Central and peripheral inhibition of gastrointestinal transit in rats: narcotics differ substantially by acting at either or both levels
F Peracchia, G Bianchi, R Fiocchi, et al.
Gastroenterology
|
October 1, 1983
Morphine tissue levels and reduction of gastrointestinal transit in rats. Correlation supports primary action site in the gut
G Bianchi, P Ferretti, M Recchia, et al.
British Journal of Pharmacology
|
April 1, 1996
Functional evidence of atypical beta 3-adrenoceptors in the human colon using the beta 3-selective adrenoceptor antagonist, SR 59230A
F De Ponti, G Gibelli, T Croci, et al.
Page
of 6